| Literature DB >> 28506260 |
Helena Giannakaki-Zimmermann1,2, Giuseppe Querques3,4, Inger Christine Munch5, Daraius Shroff6, David Sarraf7,8, Xuejing Chen7, Eduardo Cunha-Souza9,10, Sarah Mrejen11, Vittorio Capuano3, Murilo W Rodrigues9, Charu Gupta6, Andreas Ebneter1, Martin S Zinkernagel1,2, Marion R Munk12,13,14.
Abstract
BACKGROUND: To report patients with age-related macular degeneration and atypical central retinal pigment epithelium (RPE) defects not attributable to geographic atrophy (GA) or RPE-tears with overlying preserved photoreceptor layers.Entities:
Keywords: Age-related macular degeneration; Geographic atrophy; Photoreceptor; RPE tear; RPE-aperture
Mesh:
Year: 2017 PMID: 28506260 PMCID: PMC5433076 DOI: 10.1186/s12886-017-0452-0
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.209
Clinical presentation and ocular characteristics of included patients
| # | Eye | Lesion prior to RPE defect | F/u (mo) | BL BCVA | Final BCVA | Treatment after RPE defect | SRF duration (month) | OCT-A | HypoFAF area F/u | Mi-gration | RPE defect (OCT) | Presentation Fellow eye |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | OD | drusenoid PED | 36 | 20/20 | 20/20 | 3× bevacizumab | 12 | - | ↓ | + | ↓ | Drusen, RPD |
| 2 | OS | N.A. | 60 | 20/160 | 20/200 | none | 0 | - | ↓ | + | ↓ | Occult CNV |
| 3 | OS | N.A. | 120 | 20/50 | 20/200 | 2× retaane, 37× ranibizumab | persistent | No NV network | ↑ | - | ↑ | Drusenoid PED, IRC, atrophy |
| 4 | OD | drusenoid PED | 60 | 20/40 | 20/125 | 32× ranibizumab | persistent | No NV network | ↑ | - | ↑ | Drusenoid PED, RPD |
| 5 | OD | drusenoid PED | 12 | 20/25 | 20/25 | 2× ranibizumab | 7 | - | ↓ | + | ↓ | Drusen |
| 6 | OS | drusenoid PED | 36 | 20/40 | 20/63 | none | persistent | - | ↑ | - | ↑ | St.p. macular hole, Drusen |
| 7 | OS | Drusen | 6 | 20/70a | 20/30 | none | 0 | No NV network | ↓ | + | ↔ | Fibrovascular scar, Drusen |
Clinical characteristics of the 7 included patients all diagnosed with AMD and presenting with a center-involving RPE defect with intact overlying photoreceptor layers and a minimum of follow up of 6 months. All included cases were treatment naïve without evidence of a choroidal neovascularization when diagnosed
RPE retinal pigment epithelium, BCVA best corrected visual acuity, SRF subretinal fluid, BL Baseline, F/u duration of follow up between initial presentation of RPE-defect and last visit, FAF fundus autofluorescence, IRC intraretinal cysts, NV neovascular, Migration migration of subretinal drusenoid/RPE material
ainitial BCVA was performed prior to cataract surgery
Fig. 1Top: 2010: Initial presentation with drusenoid pigment epithelium detachment (PED). 2011: spontaneous resolution of PED. 2013: Spontaneous RPE aperture. The OCT reveals an RPE defect with SRF. The overlying photoreceptors are intact. Fundus autofluorescence (FAF) and fluorescein angiography (FA) shows hypoautofluorescence and pooling corresponding to RPE defect, respectively. 2014 Resolution of SRF after anti-VEGF treatment. Intact ellipsoid zone and ELM directly attached to the Bruch’s membrane. Enhanced choroidal signaling due to the absence of RPE is evident. Some ingrowth of iso-autofluorescent material is already notable on FAF (red, bold arrow). Also SD-OCT reveal some hyperreflective material (thin, red arrow) 2015 Ingrowth and regeneration of RPE/drusenoid material with consecutive decrease of enhanced choroidal signaling (thin, red arrow), hypoautofluorescence (red, bold arrow) and window defect Red (thin and bold) arrows denote hyperreflective and hyperFAF material, suggestive of potential ingrowth of drusenoid/RPE material
Fig. 22010: A circumscribed RPE atrophy is noted on color fundus with corresponding window defects visible on FA. 2011: The now performed FAF and SD-OCT highlights the loss of RPE with corresponding hypo autofluorescence on FAF and enhanced choroidal signaling on SD-OCT. The ELM, ellipsoid zone and the interdigitation zone are attached to the Bruch’s membrane. 2012 and 2013: Decrease in window defect on FA, hypoautofluorescence on FAF and enhanced choroidal signaling on SD-OCT is noted. Ingrowth of RPE/drusenoid material (red, thin arrow) is evident overlaid by PR layers
Fig. 3Initial presentation 2005 shows a large RPE atrophy on color fundus with corresponding hypoautofluorescence on FAF. A window defect with evidence of pooling within the subretinal space is visible on FA without a definite evidence of a CNV. 2007: Follow up images 2007 reveal a central RPE defect, SRF and a preserved photoreceptor (PR) layer. Obvious shedding of the PR-outer segments is evident. 2009: The RPE defect has increased in size, the SRF has persisted despite anti-VEGF therapy. The PR are present. 2015 Increase of the RPE defect, the overlying PR are still present but the lengths are reduced. The OCT angiography of the choriocapillaries confirms the absence of a CNV
Fig. 4Depicts the presentation on OCT of each included patient